RESUMO
INTRODUCTION: Mucosal leishmaniasis has a progressive course and can cause deformity and even mutilation in the affected areas. It is endemic in the American continent and it is mainly caused by Leishmania (Viannia) braziliensis. OBJECTIVE: To describe a series of mucosal leishmaniasis cases and the infectious Leishmania species. MATERIALS AND METHODS: We included 50 patients with a clinical diagnosis of mucosal leishmaniasis and parasitological confirmation, and we described their clinical and laboratory results. We performed species typing by PCR-RFLP using the miniexon sequence and hsp70 genes; confirmation was done by sequencing. RESULTS: The median time of disease evolution was 2.9 years (range: 1 month to 16 years). The relevant clinical findings included mucosal infiltration (94%), cutaneous leishmaniasis scar (74%), total loss of the nasal septum (24%), nasal deformity (22%), and mucosal ulceration (38%). The symptoms reported included nasal obstruction (90%), epistaxis (72%), rhinorrhea (72%), dysphonia (28%), dysphagia (18%), and nasal pruritus (34%). The histopathological study revealed a pattern compatible with leishmaniasis in 86% of the biopsies, and amastigotes were identified in 14% of them. The Montenegro skin test was positive in 86% of patients, immunofluorescence in 84%, and culture in 8%. Leishmania (V.) braziliensis was identified in 88% of the samples, L. (V) panamensis in 8%, and L. (V.) guyanensis and L. (L.) amazonensis in 2% respectively. CONCLUSION: In this study, we found a severe nasal disease with destruction and deformity of the nasal septum in 25% of the cases, probably associated with late diagnosis. Leishmania (V.) braziliensis was the predominant species. We described a case of mucosal leishmaniasis in Colombia caused by L. (L.) amazonensis for the first time.
Introducción. La leishmaniasis mucosa tiene un curso progresivo y puede causar deformidad e incluso mutilación de las zonas afectadas. Es endémica en el continente americano y es causada principalmente por Leishmania (Viannia) brasiliensis. Objetivo. Describir una serie de casos de leishmaniasis mucosa y las especies de Leishmania infecciosas. Materiales y métodos. Se estudiaron 50 pacientes con diagnóstico clínico de leishmaniasis mucosa y confirmación parasitológica. Se describieron sus características clínicas y los resultados de laboratorio. La tipificación de especies se hizo mediante reacción en cadena de la polimerasa de los polimorfismos de la longitud de los fragmentos de restricción (Restriction Fragment Length Polymorphism Polymerase Chain Reaction, PCR-RFLP) en la secuencia del miniexon y el gen hsp70 y se confirmó por secuenciación. Resultados. La evolución de la enfermedad fue de un mes a dieciséis años (mediana de 2,8 años). Los hallazgos clínicos fueron los siguientes: infiltración mucosa (94 %), cicatriz de leishmaniasis cutánea (74 %), pérdida total del tabique nasal (24 %), deformidad nasal (22 %) y ulceración (38 %). Los síntomas reportados fueron: obstrucción nasal (90 %), epistaxis (72 %), rinorrea (72 %), disfonía (28 %), disfagia (18 %) y prurito nasal (34 %). La histopatología mostró un patrón compatible con leishmaniasis en 86 % de las biopsias y se identificaron amastigotes en 14 % de ellas. La prueba de Montenegro fue positiva en 86 % de los pacientes, la inmunofluorescencia en 84 %, y el cultivo en 8 %. Leishmania (V.) brasiliensis se identificó en 88 % de las muestras, L. (V) panamensis en 8 %, y L. (V.) guyanensis y L. (L.) amazonensis en 2 %, respectivamente. Conclusión. Se encontró enfermedad nasal grave con destrucción y deformidad del tabique nasal en una cuarta parte de los casos, probablemente debido a un diagnóstico tardío. Leishmania (V.) brasiliensis fue la especie predominante. Se describe por primera vez un caso de leishmaniasis mucosa causado por L. (L.) amazonensis en Colombia.
Assuntos
Leishmania braziliensis/isolamento & purificação , Leishmania guyanensis/isolamento & purificação , Leishmaniose Mucocutânea/parasitologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Colômbia/epidemiologia , DNA de Protozoário/genética , Feminino , Genes de Protozoários , Proteínas de Choque Térmico HSP70/genética , Humanos , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmania guyanensis/classificação , Leishmania guyanensis/genética , Leishmaniose Mucocutânea/complicações , Leishmaniose Mucocutânea/epidemiologia , Leishmaniose Mucocutânea/patologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Proteínas de Protozoários/genética , Análise de Sequência de DNA , Pele/parasitologia , Especificidade da Espécie , Adulto JovemRESUMO
Abstract Introduction: Mucosal leishmaniasis has a progressive course and can cause deformity and even mutilation in the affected areas. It is endemic in the American continent and it is mainly caused by Leishmania (Viannia) braziliensis. Objective: To describe a series of mucosal leishmaniasis cases and the infectious Leishmania species. Materials and methods: We included 50 patients with a clinical diagnosis of mucosal leishmaniasis and parasitological confirmation, and we described their clinical and laboratory results. We performed species typing by PCR-RFLP using the miniexon sequence and hsp70 genes; confirmation was done by sequencing. Results: The median time of disease evolution was 2.9 years (range: 1 month to 16 years). The relevant clinical findings included mucosal infiltration (94%), cutaneous leishmaniasis scar (74%), total loss of the nasal septum (24%), nasal deformity (22%), and mucosal ulceration (38%). The symptoms reported included nasal obstruction (90%), epistaxis (72%), rhinorrhea (72%), dysphonia (28%), dysphagia (18%), and nasal pruritus (34%). The histopathological study revealed a pattern compatible with leishmaniasis in 86% of the biopsies, and amastigotes were identified in 14% of them. The Montenegro skin test was positive in 86% of patients, immunofluorescence in 84%, and culture in 8%. Leishmania (V.) braziliensis was identified in 88% of the samples, L. (V) panamensis in 8%, and L. (V.) guyanensis and L. (L.) amazonensis in 2% respectively. Conclusion: In this study, we found a severe nasal disease with destruction and deformity of the nasal septum in 25% of the cases, probably associated with late diagnosis. Leishmania (V.) braziliensis was the predominant species. We described a case of mucosal leishmaniasis in Colombia caused by L. (L.) amazonensis for the first time.
Resumen Introducción. La leishmaniasis mucosa tiene un curso progresivo y puede causar deformidad e incluso mutilación de las zonas afectadas. Es endémica en el continente americano y es causada principalmente por Leishmania (Viannia) brasiliensis. Objetivo. Describir una serie de casos de leishmaniasis mucosa y las especies de Leishmania infecciosas. Materiales y métodos. Se estudiaron 50 pacientes con diagnóstico clínico de leishmaniasis mucosa y confirmación parasitológica. Se describieron sus características clínicas y los resultados de laboratorio. La tipificación de especies se hizo mediante reacción en cadena de la polimerasa de los polimorfismos de la longitud de los fragmentos de restricción (Restriction Fragment Length Polymorphism Polymerase Chain Reaction, PCR-RFLP) en la secuencia del miniexon y el gen hsp70 y se confirmó por secuenciación. Resultados. La evolución de la enfermedad fue de un mes a dieciséis años (mediana de 2,8 años). Los hallazgos clínicos fueron los siguientes: infiltración mucosa (94 %), cicatriz de leishmaniasis cutánea (74 %), pérdida total del tabique nasal (24 %), deformidad nasal (22 %) y ulceración (38 %). Los síntomas reportados fueron: obstrucción nasal (90 %), epistaxis (72 %), rinorrea (72 %), disfonía (28 %), disfagia (18 %) y prurito nasal (34 %). La histopatología mostró un patrón compatible con leishmaniasis en 86 % de las biopsias y se identificaron amastigotes en 14 % de ellas. La prueba de Montenegro fue positiva en 86 % de los pacientes, la inmunofluorescencia en 84 %, y el cultivo en 8 %. Leishmania (V.) brasiliensis se identificó en 88 % de las muestras, L. (V) panamensis en 8 %, y L. (V.) guyanensis y L. (L.) amazonensis en 2 %, respectivamente. Conclusión. Se encontró enfermedad nasal grave con destrucción y deformidad del tabique nasal en una cuarta parte de los casos, probablemente debido a un diagnóstico tardío. Leishmania (V.) brasiliensis fue la especie predominante. Se describe por primera vez un caso de leishmaniasis mucosa causado por L. (L.) amazonensis en Colombia.
Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Leishmania braziliensis/isolamento & purificação , Leishmaniose Mucocutânea/parasitologia , Leishmania guyanensis/isolamento & purificação , Pele/parasitologia , Especificidade da Espécie , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Polimorfismo de Fragmento de Restrição , Leishmaniose Mucocutânea/complicações , Leishmaniose Mucocutânea/patologia , Leishmaniose Mucocutânea/epidemiologia , Proteínas de Protozoários/genética , Reação em Cadeia da Polimerase , DNA de Protozoário/genética , Análise de Sequência de DNA , Genes de Protozoários , Leishmania guyanensis/classificação , Leishmania guyanensis/genética , Colômbia/epidemiologia , Proteínas de Choque Térmico HSP70/genéticaRESUMO
Leishmania braziliensis, the main etiological agent of cutaneous leishmaniasis (CL) in Latin America, is characterized by major differences in basic biology in comparison with better-known Leishmania species. It is also associated with a high phenotypic and possibly genetic diversity that need to be more adequately defined. Here we used whole genome sequences to evaluate the genetic diversity of ten L. braziliensis isolates from a CL endemic area from Northeastern Brazil, previously classified by Multi Locus Enzyme Electrophoresis (MLEE) into ten distinct zymodemes. These sequences were first mapped using the L. braziliensis M2904 reference genome followed by identification of Single Nucleotide Polymorphisms (SNPs). A substantial level of diversity was observed when compared with the reference genome, with SNP counts ranging from ~95,000 to ~131,000 for the different isolates. When the genome data was used to infer relationship between isolates, those belonging to zymodemes Z72/Z75, recovered from forested environments, were found to cluster separately from the others, generally associated with more urban environments. Among the remaining isolates, those from zymodemes Z74/Z106 were also found to form a separate group. Phylogenetic analyses were also performed using Multi-Locus Sequence Analysis from genes coding for four metabolic enzymes used for MLEE as well as the gene sequence coding for the Hsp70 heat shock protein. All 10 isolates were firmly identified as L. braziliensis, including the zymodeme Z26 isolate previously classified as Leishmania shawi, with the clustering into three groups confirmed. Aneuploidy was also investigated but found in general restricted to chromosome 31, with a single isolate, from zymodeme Z27, characterized by extra copies for other chromosomes. Noteworthy, both Z72 and Z75 isolates are characterized by a much reduced heterozygosity. Our data is consistent with the existence of distinct evolutionary groups in the restricted area sampled and a substantial genetic diversity within L. braziliensis.
Assuntos
Ecótipo , Variação Genética , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmaniose Cutânea/parasitologia , Brasil , Humanos , Leishmania braziliensis/isolamento & purificação , Polimorfismo de Nucleotídeo Único , Análise de Sequência de DNA , Sequenciamento Completo do GenomaRESUMO
A variety of clinical forms of American cutaneous leishmaniasis (ACL) caused by Leishmania braziliensis, as well as differing immune responses of patients, have been reported for an ACL focus in the state of Minas Gerais, Brazil. In addition, two genetic profiles of L. braziliensis have been described, of which one variant profile (hsp70-variant) has been associated with atypical lesions. We investigated the biological behavior of genetic variant strains of L. braziliensis isolated from patients with different clinical manifestations of ACL. Experimental infections were performed with golden hamsters for five L. braziliensis strains in standardized doses of 1 × 106 parasites per inocula. The characteristics of skin lesions, histopathological features, and parasite burden were independently analyzed at 30 and 60 days post-infection. The data revealed distinct patterns in the onset time of visible skin lesions as well as in lesion size and parasite burden among the strains. The extent and density of the inflammatory infiltrate differed among strains, although cellular composition of granulomas appeared similar. Multivariate analysis indicated the occurrence of two clusters: one comprising native strains (cluster 1) and one comprising the reference strain (cluster 2). Within cluster 1, the genetic variants of L. braziliensis did not group with the non-variant strain suggesting that the distinct patterns of biological behavior of these strains could be associated with the known genetic diversity previously described for them.
Assuntos
Variação Genética/genética , Leishmania braziliensis/genética , Leishmaniose Cutânea/patologia , Pele/patologia , Adulto , Animais , Brasil/epidemiologia , Cricetinae , Proteínas de Choque Térmico HSP70/genética , Humanos , Leishmania braziliensis/classificação , Leishmania braziliensis/isolamento & purificação , Leishmaniose Cutânea/epidemiologia , Leishmaniose Cutânea/parasitologia , Masculino , Mesocricetus/parasitologia , Pele/parasitologiaRESUMO
The present study demonstrates that the Leishmania (Viannia) braziliensis strain MCAN/BR/1998/R619 is composed of multiple subpopulations with measurable distinctions. Single parasites were separated from a culture of promastigotes in stationary phase by cell sorting and then cultivated as subpopulations. Subsequently, these subpopulations were evaluated for features of in vitro growth, infectivity to murine macrophages and proteinase gene expression. The first evidence of distinct characteristics was observed during the in vitro cultivation of isolated subpopulations, as distinct clusters of patterns were formed among the cultures, indicating the existence of quantifiable fluctuations in metrics. Further, when infecting murine macrophages, the subpopulations induced distinct patterns of production of immune response mediators. While some subpopulations mainly induced the production of IL-1ß, IL-6 and TNF-α, others induced the production of IL-12p70 and nitric oxide. Finally, amastigotes of these subpopulations had higher expression of proteinase genes than promastigotes. Additionally, cysteine proteinase, serine proteinase, metalloproteinase and aspartic proteinases were differentially expressed in promastigote and amastigote forms. These data suggest the existence of distinct profiles for the L. (V.) braziliensis MCAN/BR/1998/R619 strain and subpopulations that could drive the success of parasite adaptation to the environments that they inhabit.
Assuntos
Leishmania braziliensis/crescimento & desenvolvimento , Animais , Humanos , Interleucina-1beta/imunologia , Interleucina-6/imunologia , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmania braziliensis/isolamento & purificação , Leishmaniose Cutânea/imunologia , Leishmaniose Cutânea/parasitologia , Macrófagos/imunologia , Macrófagos/parasitologia , Camundongos , Peptídeo Hidrolases/genética , Peptídeo Hidrolases/metabolismo , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , Fator de Necrose Tumoral alfa/imunologiaRESUMO
This work developed a simple empirical algorithm to distinguish three Leishmania species using MALDI-TOF mass spectrometry. It suggests that complicated computer algorithms may not always be necessary for clinically useful microbiology applications.
Assuntos
Leishmania braziliensis/química , Leishmania braziliensis/classificação , Leishmaniose Cutânea/parasitologia , Técnicas Microbiológicas/métodos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Algoritmos , HumanosRESUMO
Resumen Introducción. La leishmaniasis cutánea es una enfermedad causada por parásitos del género Leishmania que tiene gran incidencia en Colombia. El diagnóstico y la identificación de la especie infecciosa son factores críticos en el momento de escoger e iniciar el tratamiento. Actualmente, los métodos de diagnóstico y tipificación requieren procedimientos complejos, por lo que es necesario validar nuevos marcadores moleculares y métodos que simplifiquen el proceso. Objetivo. Desarrollar una herramienta basada en la reacción en cadena de la polimerasa (PCR) con curvas de fusión (High Resolution Melting; PCR-HRM) para el diagnóstico y tipificación de las tres especies de Leishmania de importancia epidemiológica en casos de leishmaniasis cutánea en Colombia. Materiales y métodos. Los genomas de Leishmania panamensis, L. braziliensis y L. guyanensis se compararon mediante métodos bioinformáticos. Las regiones específicas de especie identificadas se validaron mediante PCR. Para los marcadores seleccionados se diseñó una PCR-HRM y se estimaron algunos parámetros de validez y seguridad usando aislamientos de pacientes colombianos caracterizados previamente mediante PCR y análisis de polimorfismos en la longitud de los fragmentos de restricción (Restriction Fragment Length Polymorphism - RFLP; PCR-RFLP) del gen hsp70. Resultados. El análisis genómico comparativo mostró 24 regiones específicas de especie. Sin embargo, la validación mediante PCR solo identificó un marcador específico para cada especie de Leishmania. Los otros marcadores mostraron amplificación cruzada. El límite de detección para los tres marcadores seleccionados fue de un parásito, mientras que la sensibilidad, la especificidad, el valor predictivo positivo y el negativo fueron de 91,4, 100, 100 y 75 %, respectivamente. Conclusiones. Las tres regiones seleccionadas pueden emplearse como marcadores moleculares en el diagnóstico y tipificación de las especies causantes de la leishmaniasis cutánea en Colombia.
Abstract Introduction: Cutaneous leishmaniasis, caused by parasites of the genus Leishmania, is a disease with high incidence in Colombia. The diagnosis and identification of the infectious species are critical factors when selecting and initiating treatment. Currently, the methods for diagnosing and typing cutaneous leishmaniasis require complicated procedures and there is a need for the validation of new molecular markers and methods to simplify the process. Objective: To develop a tool based in PCR melting curves (PCR-HRM) for the diagnosis and typing of the three Leishmania species of epidemiological importance for cutaneous leishmaniasis in Colombia. Materials and methods: The genomes of Leishmania panamensis, L. braziliensis and L. guyanensis were compared with bioinformatic methods. The species-specific regions were then validated using PCR. For the selected markers, a PCR-HRM was designed, and validity and security parameters were estimated using isolates from Colombian patients previously characterized by PCR-RFLP of the hsp70 gene. Results: The comparative genomic analysis yielded 24 species-specific regions. However, the PCR validation identified only one marker that was specific to each Leishmania species. The other markers showed cross amplification. The detection limit for the three selected markers was one parasite. The sensitivity, specificity, predictive positive and negative values were 91.4%, 100%, 100% and 75%, respectively. Conclusions: The three selected regions can be used as molecular markers in the diagnosis and typing of the causative species of cutaneous leishmaniasis in Colombia.
Assuntos
Humanos , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Reação em Cadeia da Polimerase , Leishmaniose Cutânea/diagnóstico , Leishmania guyanensis/classificação , ColômbiaRESUMO
BACKGROUND: Forty-four strains isolated from a cohort of cutaneous leishmaniasis (CL) patients who did or did not respond to one course of treatment with meglumine antimoniate were investigated to explore genetic polymorphisms in parasite kinetoplast DNA minicircles. Leishmania (Viannia) braziliensis strains isolated from responder (R) and non-responder (NR) patients who acquired infection in Rio de Janeiro or in other Brazilian states were studied using low-stringency single-specific primer polymerase chain reaction (LSSP-PCR) to identify genetic polymorphisms. RESULTS: Polymorphisms were observed in parasites recovered from patient lesions. No association was found between a specific genotype and R or NR patients. Phenetic analysis grouped the genotypes into three main clusters, with similarity indices varying from 0.72 to 1.00. Although no specific genotype association was detected, at least one group of L. (V.) braziliensis genotypes that circulates in Rio de Janeiro was discriminated in clusters I and III, showing phenotypes of good and poor responses to treatment, respectively. Cluster I comprised parasite profiles recovered from R patients from Rio de Janeiro and in cluster III, NR samples were prevalent. Cluster II comprised 24 isolates, with 21 from Rio de Janeiro and three from other states, equally distributed between R and NR patients. Additionally, we found that parasites sharing all common genetic characteristics acted differently in response to treatment. CONCLUSIONS: These results are of clinical-epidemiological importance since they demonstrate that populations of L. (V.) braziliensis that exhibit high levels of genetic similarity also display different phenotypes associated with meglumine antimoniate responses in cutaneous leishmaniasis patients.
Assuntos
Antiprotozoários/uso terapêutico , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmaniose Cutânea/tratamento farmacológico , Leishmaniose Cutânea/parasitologia , Meglumina/uso terapêutico , Compostos Organometálicos/uso terapêutico , Adolescente , Adulto , Fatores Etários , Antiprotozoários/farmacologia , Brasil , Criança , Análise por Conglomerados , Estudos de Coortes , DNA de Cinetoplasto/genética , Eletroforese em Gel de Ágar , Feminino , Genótipo , Humanos , Leishmania braziliensis/efeitos dos fármacos , Masculino , Meglumina/farmacologia , Antimoniato de Meglumina , Pessoa de Meia-Idade , Compostos Organometálicos/farmacologia , Fenótipo , Projetos Piloto , Reação em Cadeia da Polimerase , Polimorfismo Genético , Adulto JovemRESUMO
BACKGROUND: Leishmaniases are parasitic vector-borne diseases affecting more than 12 million people in 98 countries. In Colombia, leishmaniasis is widespread and the most common clinical manifestation is cutaneous, mainly caused by L. panamensis and L. braziliensis. Currently, the genetic diversity of these species in Colombia is unknown. To address this, we applied molecular techniques for their characterization, using multilocus sequence typing (MLST) to explore the genetic variability and phylodynamics of the disease. METHODS: Seven previously described genetic markers were selected highlighting the implementation of a mitochondrial marker. Markers were applied to 163 samples from isolates obtained between 1980 and 2001. RESULTS: The identification of the samples showed an excellent correlation with typing tests previously applied (MLEE, monoclonal antibodies). Isolates of L. braziliensis showed greater genetic diversity than L. panamensis, and a greater number of diploid sequence types (DSTs). In addition, the geographical distribution of DSTs for each species were obtained through georeferencing maps. CONCLUSIONS: To our knowldge, this study represents the first description of the genetic variability of L. panamensis in Colombia and South America, and is the first to propose a scheme of MLST for epidemiological surveillance of leishmaniasis in the country.
Assuntos
Variação Genética , Leishmania braziliensis/genética , Leishmania guyanensis/genética , Leishmaniose Cutânea/parasitologia , Tipagem de Sequências Multilocus/métodos , Animais , Colômbia/epidemiologia , DNA de Protozoário/genética , Marcadores Genéticos , Humanos , Leishmania braziliensis/classificação , Leishmania braziliensis/isolamento & purificação , Leishmania guyanensis/classificação , Leishmania guyanensis/isolamento & purificação , Leishmaniose Cutânea/epidemiologia , Filogenia , América do Sul/epidemiologiaRESUMO
Introducción. La leishmaniasis cutánea es una enfermedad causada por parásitos del género Leishmania que tiene gran incidencia en Colombia. El diagnóstico y la identificación de la especie infecciosa son factores críticos en el momento de escoger e iniciar el tratamiento. Actualmente, los métodos de diagnóstico y tipificación requieren procedimientos complejos, por lo que es necesario validar nuevos marcadores moleculares y métodos que simplifiquen el proceso.Objetivo. Desarrollar una herramienta basada en la reacción en cadena de la polimerasa (PCR) con curvas de fusión (High Resolution Melting; PCR-HRM) para el diagnóstico y tipificación de las tres especies de Leishmania de importancia epidemiológica en casos de leishmaniasis cutánea en Colombia.Materiales y métodos. Los genomas de Leishmania panamensis, L. braziliensis y L. guyanensis se compararon mediante métodos bioinformáticos. Las regiones específicas de especie identificadas se validaron mediante PCR. Para los marcadores seleccionados se diseñó una PCR-HRM y se estimaron algunos parámetros de validez y seguridad usando aislamientos de pacientes colombianos caracterizados previamente mediante PCR y análisis de polimorfismos en la longitud de los fragmentos de restricción (Restriction Fragment Length Polymorphism - RFLP; PCR-RFLP) del gen hsp70.Resultados. El análisis genómico comparativo mostró 24 regiones específicas de especie. Sin embargo, la validación mediante PCR solo identificó un marcador específico para cada especie de Leishmania. Los otros marcadores mostraron amplificación cruzada. El límite de detección para los tres marcadores seleccionados fue de un parásito, mientras que la sensibilidad, la especificidad, el valor predictivo positivo y el negativo fueron de 91,4, 100, 100 y 75 %, respectivamente.Conclusiones. Las tres regiones seleccionadas pueden emplearse como marcadores moleculares en el diagnóstico y tipificación de las especies causantes de la leishmaniasis cutánea en Colombia.
Assuntos
Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmania guyanensis/classificação , Leishmaniose Cutânea/diagnóstico , Reação em Cadeia da Polimerase , Colômbia , HumanosRESUMO
The production of ergosterol lipid, important for the Leishmania membrane homeostasis, involves different enzymes. This pathway can be blocked to azoles and allylamines drugs, such as Butenafine. The aim of the present work was to evaluate the anti-leishmanicidal activity of this drug in 2 major species of Leishmania responsible for causing the American tegumentar leishmaniasis (L. (L.) amazonensis and L. (V.) braziliensis). Butenafine eliminated promastigote forms of L. amazonensis and L. braziliensis with efficacy similar to miltefosine, a standard anti-leishmania drug. In addition, butenafine induced alterations in promastigote forms of L. amazonensis that resemble programmed cell death. Butenafine as well as miltefosine presented mild toxicity in peritoneal macrophages, however, butenafine was more effective to eliminate intracellular amastigotes of both L. amazonensis and L. braziliensis, and this effect was not associated with elevated levels of nitric oxide or hydrogen peroxide. Taken together, data presented herein suggests that butenafine can be considered as a prototype drug able to eliminate L. amazonensis and L. braziliensis, etiological agents of anergic diffuse and mucocutaneous leishmaniasis, respectively.
Assuntos
Antifúngicos/uso terapêutico , Antiprotozoários/uso terapêutico , Benzilaminas/uso terapêutico , Leishmania braziliensis/efeitos dos fármacos , Leishmaniose Tegumentar Difusa/tratamento farmacológico , Leishmaniose Mucocutânea/tratamento farmacológico , Naftalenos/uso terapêutico , Fosforilcolina/análogos & derivados , Animais , Reposicionamento de Medicamentos , Feminino , Leishmania braziliensis/classificação , Leishmaniose Tegumentar Difusa/parasitologia , Leishmaniose Mucocutânea/parasitologia , Macrófagos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Testes de Sensibilidade Parasitária , Fosforilcolina/uso terapêuticoRESUMO
The double stranded RNA (dsRNA) virus Leishmaniavirus (Totiviridae) was first described in Leishmania guyanensis and L. braziliensis (LRV1), and more recently from L. major and L. aethiopica (LRV2). Parasites bearing LRV1 elicit a higher pro-inflammatory profile, arising through activation of Toll like receptor 3(TLR3) interacting with the viral dsRNA. LRV1 is most common in Leishmania from the Amazon region; however data for other regions of Brazil are more limited. Here we applied PCR tests with validated 'universal' LRV1 primers to search for LRV1 in 40 strains of cultured L. braziliensis from several locales within Minas Gerais State, including patients presenting with atypical lesion pathology. All strains were negative however. These data are in agreement with results from other areas of Southeastern Brazil that LRV1 is relatively uncommon.
Assuntos
Leishmania braziliensis/classificação , Leishmaniose Cutânea/epidemiologia , Leishmaniose Cutânea/parasitologia , Brasil/epidemiologia , Geografia Médica , Humanos , Leishmania braziliensis/isolamento & purificação , Vigilância da População , PrevalênciaRESUMO
A precise identification of Leishmania species involved in human infections has epidemiological and clinical importance. Herein, we describe a preliminary validation of a restriction fragment length polymorphism assay, based on the calmodulin intergenic spacer region, as a tool for detecting and typing Leishmania species. After calmodulin amplification, the enzyme HaeIII yielded a clear distinction between reference strains of Leishmania mexicana, Leishmania amazonensis, Leishmania infantum, Leishmania lainsoni, and the rest of the Viannia reference species analyzed. The closely related Viannia species: Leishmania braziliensis, Leishmania panamensis, and Leishmania guyanensis, are separated in a subsequent digestion step with different restriction enzymes. We have developed a more accessible molecular protocol for Leishmania identification/typing based on the exploitation of part of the calmodulin gene. This methodology has the potential to become an additional tool for Leishmania species characterization and taxonomy.
Assuntos
Calmodulina/genética , Leishmania braziliensis/classificação , Leishmania guyanensis/classificação , Leishmania infantum/classificação , Leishmania mexicana/classificação , Tipagem Molecular/métodos , DNA de Protozoário/genética , Humanos , Leishmania braziliensis/genética , Leishmania braziliensis/isolamento & purificação , Leishmania guyanensis/genética , Leishmania guyanensis/isolamento & purificação , Leishmania infantum/genética , Leishmania infantum/isolamento & purificação , Leishmania mexicana/genética , Leishmania mexicana/isolamento & purificação , Leishmaniose/diagnóstico , Leishmaniose/parasitologia , Reação em Cadeia da Polimerase/métodos , Polimorfismo de Fragmento de Restrição , Proteínas de Protozoários/genéticaAssuntos
Surtos de Doenças , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmaniose Cutânea/epidemiologia , Leishmaniose Cutânea/parasitologia , Adulto , Feminino , Guiana Francesa/epidemiologia , Variação Genética , Humanos , Leishmaniose Cutânea/diagnóstico , Masculino , Filogenia , Vigilância da PopulaçãoRESUMO
Leishmaniasis is a vector borne disease caused by protozoa of the genus Leishmania. Human leishmaniasis is not endemic in Australia though imported cases are regularly encountered. This study aimed to provide an update on the molecular epidemiology of imported leishmaniasis in Australia. Of a total of 206 biopsies and bone marrow specimens submitted to St Vincent's Hospital Sydney for leishmaniasis diagnosis by PCR, 55 were found to be positive for Leishmania DNA. All PCR products were subjected to restriction fragment length polymorphism analysis for identification of the causative species. Five Leishmania species/species complexes were identified with Leishmania tropica being the most common (30/55). Travel or prior residence in a Leishmania endemic region was the most common route of acquisition with ~47% of patients having lived in or travelled to Afghanistan. Cutaneous leishmaniasis was the most common manifestation (94%) with only 3 cases of visceral leishmaniasis and no cases of mucocutaneous leishmaniasis encountered. This report indicates that imported leishmaniasis is becoming increasingly common in Australia due to an increase in global travel and immigration. As such, Australian clinicians must be made aware of this trend and consider leishmaniasis in patients with suspicious symptoms and a history of travel in endemic areas. This study also discusses the recent identification of a unique Leishmania species found in native kangaroos and a potential vector host which could create the opportunity for the establishment of a local transmission cycle within humans.
Assuntos
DNA de Protozoário/genética , Leishmania braziliensis/genética , Leishmania donovani/genética , Leishmania tropica/genética , Leishmaniose Cutânea/epidemiologia , Leishmaniose Visceral/epidemiologia , Adolescente , Adulto , Afeganistão/epidemiologia , Idoso , Criança , Pré-Escolar , DNA de Protozoário/isolamento & purificação , Emigrantes e Imigrantes/estatística & dados numéricos , Feminino , Humanos , Leishmania braziliensis/classificação , Leishmania braziliensis/isolamento & purificação , Leishmania donovani/classificação , Leishmania donovani/isolamento & purificação , Leishmania tropica/classificação , Leishmania tropica/isolamento & purificação , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/parasitologia , Leishmaniose Cutânea/patologia , Leishmaniose Visceral/diagnóstico , Leishmaniose Visceral/parasitologia , Leishmaniose Visceral/patologia , Masculino , Pessoa de Meia-Idade , Epidemiologia Molecular , Tipagem Molecular , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Viagem/estatística & dados numéricos , Adulto JovemRESUMO
With the emergence of leishmaniasis in new regions around the world, molecular epidemiological methods with adequate discriminatory power, reproducibility, high throughput and inter-laboratory comparability are needed for outbreak investigation of this complex parasitic disease. As multilocus sequence analysis (MLSA) has been projected as the future gold standard technique for Leishmania species characterization, we propose a MLSA panel of six housekeeping gene loci (6pgd, mpi, icd, hsp70, mdhmt, mdhnc) for investigating intraspecific genetic variation of L. (Viannia) braziliensis strains and compare the resulting genetic clusters with several epidemiological factors relevant to outbreak investigation. The recent outbreak of cutaneous leishmaniasis caused by L. (V.) braziliensis in the southern Brazilian state of Santa Catarina is used to demonstrate the applicability of this technique. Sequenced fragments from six genetic markers from 86 L. (V.) braziliensis strains from twelve Brazilian states, including 33 strains from Santa Catarina, were used to determine clonal complexes, genetic structure, and phylogenic networks. Associations between genetic clusters and networks with epidemiological characteristics of patients were investigated. MLSA revealed epidemiological patterns among L. (V.) braziliensis strains, even identifying strains from imported cases among the Santa Catarina strains that presented extensive homogeneity. Evidence presented here has demonstrated MLSA possesses adequate discriminatory power for outbreak investigation, as well as other potential uses in the molecular epidemiology of leishmaniasis.
Assuntos
Surtos de Doenças/estatística & dados numéricos , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmaniose Cutânea/parasitologia , Epidemiologia Molecular/métodos , Tipagem de Sequências Multilocus/métodos , Brasil/epidemiologia , Humanos , Leishmania braziliensis/isolamento & purificação , Leishmaniose Cutânea/epidemiologia , FilogeniaRESUMO
American tegumentary leishmaniasis (ATL) is a group of zoonotic diseases caused by kinetoplastid flagellates of the genus Leishmania. A total of 66 patients diagnosed as positive ATL cases from northwest Argentina were included in this study. Leishmania stocks were isolated in vitro and analyzed over promastigote cultures sown on FTA through nested PCR and sequence of cytochrome b (cyt b). The molecular analysis resulted in the incrimination of L. (Viannia) braziliensis as the predominant species in the studied area, identifying two genotypes of L. (V.) braziliensis, 24 cases of Ab-1 cyt b and 41 cases of Ab-2 cyt b. One L. (V.) guyanensis strain was obtained from a traveler from the Brazilian Amazon. The prevalence of different genotypes was in agreement with previous studies, suggesting the necessity for new systems to study the genetic diversity in more detail. Most of the cases typified in this study were registered in the area of Zenta Valley (Orán, Hipólito Yrigoyen, and Pichanal cities), pointing a link between genotype and geographical origin of the sample. Sex and age distribution of the patients indicate that the transmission was predominantly associated with rural areas or rural activities, although the results might not exclude the possibility of peri-urban transmission. This work represents, so far, the largest isolation and molecular characterization of ATL cases in Argentina.
Assuntos
Citocromos b/classificação , Leishmania braziliensis/isolamento & purificação , Leishmania/isolamento & purificação , Leishmaniose Cutânea/epidemiologia , Filogenia , Proteínas de Protozoários/classificação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Argentina/epidemiologia , Criança , Pré-Escolar , Citocromos b/genética , Feminino , Genótipo , Humanos , Lactente , Recém-Nascido , Leishmania/classificação , Leishmania/genética , Leishmania braziliensis/classificação , Leishmania braziliensis/genética , Leishmaniose Cutânea/parasitologia , Masculino , Pessoa de Meia-Idade , Prevalência , Proteínas de Protozoários/genéticaRESUMO
As diversas espécies de Leishmania são parasitas de considerável importância médica e econômica. As drogas atualmente utilizadas no tratamento da leishmaniose apresentam efeitos adversos, alta toxicidade, elevado custo e surgimento de cepas resistentes. Nesse contexto, inibidores proteolíticos é uma alternativa para o tratamento desta doença. Este estudo está focado nas calpaínas, que compreendem uma família de cisteína peptidases neutras dependentes de cálcio, envolvidas numa ampla variedade de funções fisiológicas. As calpaínas estão envolvidas em importantes doenças humanas, portanto inibidores de calpaínas já vêm sendo desenvolvidos e testados para o tratamento dessas doenças, alguns encontra-se em estágios avançados de triagem clínica. Dessa forma, o presente trabalho avalia a expressão e identificação de homólogos das calpaínas em Leishmania braziliensis e o efeito do inibidor de calpaínas MDL28170 em ensaios in vitro. Através da busca por sequências no GenBank, alinhamentos múltiplos, filogenia e análise de domínios conservados nas sequências obtidas, selecionamos como alvo inicial sequências de calpaínas que possuíam o maior número de domínios conservados. A análise da expressão gênica relativa indica que 13 das 20 calpaínas estudadas apresentam níveis constitutivos de mRNA nas formas procíclica e metacíclica de L. braziliensis. A expressão de cinco alvos é maior na forma procíclica, e a de um alvo é maior na forma metacíclica e há expressão estágio específica de apenas um alvo na forma procíclica. [...]
Em ensaios de Western blotting,verificamos que o anticorpo foi capaz de reagir contra uma proteína de 50 kDa. Já na imunolocalização foi possível observar calpaínas dispersas no citoplasma, membrana e núcleo. Além disso, através de citometria de fluxo, as moléculas homólogas às calpaínas foram identificadas em maior abundância no interior das células. Nos ensaios de inibição com o MDL28170, inibidor de calpaínas, foi possível observar a redução da proliferação nas formas promastigotas recém isoladas e múltiplas passagens de forma dose-dependente nas diferentes concentrações do inibidor ao longo de quatro dias. O efeito reversíveldo inibidor também foi avaliado nas formas promastigotas, com taxas menores comparado com o controle. O efeito do inibidor, também foi capaz de diminuir de maneira dose-dependente o índice de associação e aumentou o percentual de células com parasitos aderidos durante o processo de interação com macrófagos peritoneais. O parasito aumentou a expressão de uma peptidse clássica (gp63) quando tratado com o MDL28170, já a expressão de calpaínas e cpb não foi alterada pelo estresse induzido pelo composto. Estes dados sugerem mais estudos para melhor caracterizar as calpaínas em L. braziliensis e sugerem uma maior avaliação para uma possível associação de moléculas similares as calpaínas com a virulência ou não do parasito. Assim este trabalho acrescenta novas possibilidades para a utilização de inibidores de calpaínas como um potencial alvo de desenvolvimento para o tratamento da leishmaniose.
The various species of Leishmania are parasites of considerable medical and economicimportance. The drugs used in the treatment of leishmaniasis have adverse effects, high toxicity,high cost and emergence of resistant strains. In this context, proteolytic inhibitors could be analternative for the treatment of this disease. This study is focused on calpains, which comprise afamily of neutral cysteine peptidases, which are strictly dependent of calcium, and are there ofknown as Calcium Dependent Peptidases.These enzymes play a variety of physiologicalfunctions, and are involved in human diseases, therefore calpains inhibitors are under trial totreat these diseases. Thus, this study aimed to assess calpain expression levels in Leishmaniabraziliensis, as well as the effect of the calpain inhibitor MDL28170 in vitro. Through thesearching for sequencesin GenBank, multiple alignments, and phylogenetic analysis of theobtained sequences conserved domains, selected as an initial target sequences of calpain whichpossessed the greatest number of conserved domains. In this sense, we assessed the expressionlevels of mRNA from a group of twenty sequences containing archetypal calpain domain. Theanalysis indicated that 13 out of the 20 studied calpains have constitutive levels of mRNAbetween the procyclic and metacyclic forms of L. braziliensis, while five calpains presentedhigher expression levels at the procyclic stage, and only one sequence is augmented at themetacyclic stage. One calpain molecule was found to be procyclic-specific.
[...] In Western blotting assays, we found that the anti-calpainTriTryp antibody was able to recognize a 50 kDa protein. The immunolocalization assaysrevealed calpain molecules present at the membrane, nucleus and dispersed throughout thecytoplasm. Also, by flow cytometry, molecules homologous to calpains have been identified inabundance within cells. In inhibition assays employing MDL28170, a potent and specificcalpain inhibitor, it was possible to observe a dose-dependent reduction in the proliferation rate,either in freshly isolated promastigotes or multiple passages parasites. MDL28170 presents areversible inhibitory effect. The inhibitor was also able to decrease in a dose-dependent mannerthe association index and the percentage of host cells with attached parasites during the processof interaction with peritoneal macrophages. Finally, MDL28170 enhanced the expression ofgp63 molecules, while cpb and calpains expression were not affect. Further studies to bettercharacterize the calpain in L. braziliensis should be performed, aiming to add new possibilitiesfor the exploitation of calpain inhibitors as a potential for the treatment of leishmaniasis.
Assuntos
Calpaína , Leishmania braziliensis/classificação , Leishmaniose/tratamento farmacológico , Peptídeo Hidrolases , Western BlottingRESUMO
American cutaneous leishmaniasis (ACL) caused by Leishmania (Viannia) braziliensis is a neglected disease of humans in the New World that may also cause irreversible skin and eventually mucocutaneous lesions. This parasite can also infect dogs and represents a diagnostic challenge for veterinarians. Methods currently available for the diagnosis of ACL have a low sensitivity and may be time-consuming, representing a limit for treatment expedition of ACL. Quantitative real time PCR assays (qPCR) for the detection of L. (V.) braziliensis in canine blood samples were developed herein, and the detection limit and specificity of different molecular targets (kDNA and rDNA) evaluated. Of the protocols assessed, two qPCR assays, one targeting the kDNA and other the SSU rDNA of L. (V.) braziliensis, performed better, with detection limits of 100 fg and 10 pg, respectively. These assays were also used to test skin samples from humans with suspected ACL. The results indicate that the qPCR protocols developed represent an advance for the diagnosis of ACL in dogs and humans from this region, and provide a rapid and non-invasive diagnosis of the infection by L. (V.) braziliensis. Considering the quantitative nature of the assays, they will also be useful for monitoring treatment efficacy and preventing relapses in human patients in Brazil, although further studies are needed to critically evaluate the specificity of the qPCRs for their capacity to distinguish different Leishmania species and subspecies (represented by zymodemes) in other countries. Finally, molecular assays established may represent new tools for future basic and applied research focused on species identification, host-parasite associations, and infection dynamics in host and vector populations.
Assuntos
Doenças do Cão/diagnóstico , Leishmania braziliensis/genética , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/veterinária , Animais , DNA Ribossômico/química , Doenças do Cão/parasitologia , Cães , Humanos , Leishmania braziliensis/classificação , Leishmaniose Cutânea/parasitologia , Doenças Negligenciadas , Reação em Cadeia da Polimerase em Tempo RealRESUMO
Leishmania (Viannia) braziliensis causes three main types of American tegumentary leishmaniasis (ATL), localized cutaneous leishmaniasis (CL), mucosal leishmaniasis (ML), and disseminated leishmaniasis (DL). All forms are observed among individuals of Corte de Pedra, Brazil. We previously used random amplified markers to identify a multiclonal population among L. (V.) braziliensis isolates from ATL patients, defining parasite clades associated with different clinical syndromes. Herein we compared sequences of random amplified markers to identify genotypes of L. (V.) braziliensis recovered from lesions of CL, ML, and DL patients. Six polymorphic genomic loci were sequenced from 35 parasite isolates. Single-nucleotide polymorphisms (SNPs) and insertions-deletions (indels) at each locus allowed us to segregate the L. (V.) braziliensis population according to haplotypes. Several SNPs, indels, and haplotypes were significantly associated with an increased risk of DL. Molecular genotyping may provide markers to identify L. (V.) braziliensis strains likely to cause this emerging, hard-to-treat form of ATL.